Sign in

CIK 0001913577

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Semnur Pharmaceuticals, Inc.

Sign in to watch
Tickers
SMNR SMNRW
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
981659463
Phone
+1 650-516-4310
Business address
960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
Former names
Denali Capital Acquisition Corp.

Securities

  • SMNR Common stock OTC
  • SMNRW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-15 Scilex Holding Co 10% owner Other disposition −7,034,737 174,770,112
2025-09-23 Scilex Holding Co 10% owner Sale −11,945,151 $16.00 $191.1M 181,804,849
2025-09-23 Scilex Holding Co 10% owner Sale −554,849 $16.00 $8.9M 500,000
2024-08-30 Denali Capital Global Investments LLC 10% owner Sale · Class B Ordinary Shares −500,000 1,432,500
2024-08-30 Xu Jiandong 10% owner Sale · Class B Ordinary Shares −500,000 1,432,500
2022-05-21 Xu Jiandong 10% owner Returned to the company · Class B Ordinary Shares −93,750 1,932,500
2022-05-21 Denali Capital Global Investments LLC 10% owner Returned to the company · Class B Ordinary Shares −93,750 1,932,500
2022-04-11 Denali Capital Global Investments LLC 10% owner Purchase +510,000 $10.00 $5.1M 510,000
2022-04-11 Xu Jiandong 10% owner Purchase +510,000 $10.00 $5.1M 510,000

Page 1 of 1 · 9 trades